Drug intelligence / Profile preview

(8r,9z,12z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid

Development stage: Unknown
Modality: Small Molecules
Administration: Unknown

Overview

This compound is a derivative of linoleic acid and belongs to the class of organic compounds known as linoleic acids and derivatives. It features an 18-carbon chain with two double bonds at positions 9 and 12 (cis configuration), a hydroxyl group at position 8 in the R configuration (stereocenter), and a ketone group at position 6. The molecule has been studied for its potential as a peroxisome proliferator-activated receptor gamma (PPARγ) ligand[1][2][3].

Other names: (8R,9Z,12Z)-8-Hydroxy-6-oxo-9,12-octadecadienoic acid9,12-Octadecadienoic acid, 8-hydroxy-6-oxo-, (8R,9Z,12Z)-Acide (8R,9Z,12Z)-8-hydroxy-6-oxo-9,12-octadécadiénoïque

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on (8r,9z,12z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on (8r,9z,12z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid.

Explore the full profile